For the quarter ending 2026-03-31, TARA has $191,923K in assets. $10,715K in debts. $14,737K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,737 | 49,657 | 12,551 | 31,496 |
| Marketable debt securities | 121,049 | 105,897 | 120,119 | 90,720 |
| Prepaid expenses and other current assets | 4,211 | 3,950 | 2,974 | 2,875 |
| Total current assets | 139,997 | 159,504 | 135,644 | 125,091 |
| Restricted cash, non-current | 745 | 745 | 745 | 745 |
| Marketable debt securities, non-current | 41,641 | 42,336 | 957 | 23,392 |
| Property and equipment, gross | - | 2,227 | - | - |
| Less accumulated depreciation | - | 1,468 | - | - |
| Property and equipment, net | 669 | 759 | 828 | 912 |
| Operating lease right-of-use asset | 2,891 | 3,174 | 3,452 | 3,725 |
| Other assets | 5,980 | 2,950 | 3,010 | 3,068 |
| Total assets | 191,923 | 209,468 | 144,636 | 156,933 |
| Accounts payable | 4,031 | 3,468 | 4,504 | 5,299 |
| Accrued expenses and other current liabilities | 3,627 | 6,229 | 4,185 | 3,263 |
| Operating lease liability | 1,264 | 1,242 | 1,220 | 1,199 |
| Total current liabilities | 8,922 | 10,939 | 9,909 | 9,761 |
| Operating lease liability, non-current | 1,793 | 2,117 | 2,436 | 2,749 |
| Total liabilities | 10,715 | 13,056 | 12,345 | 12,510 |
| Common stock, 55,055,582 and 53,587,260 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 55 | 54 | 39 | 39 |
| Additional paid-in capital | 501,718 | 498,687 | 417,221 | 416,161 |
| Accumulated deficit | -320,201 | -302,419 | -285,112 | -271,854 |
| Accumulated other comprehensive income (loss) | -364 | 90 | 143 | 77 |
| Total stockholders equity | 181,208 | 196,412 | 132,291 | 144,423 |
| Total liabilities and stockholders equity | 191,923 | 209,468 | 144,636 | 156,933 |
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)